Nasal spray from stem cells for treatment-resistant schizophrenia
Part of Brain & nervous system, Ear, nose & throat, Mental health clinical trials.
This study tests whether a nasal spray containing tiny particles from dental stem cells (called exosomes) is safe and can help with 'negative symptoms' of schizophrenia, such as lack of motivation or emotion. It's a very early-stage trial for people who haven't gotten enough relief from standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia.
- You are between 18 and 60 years old.
- You have been in the hospital for more than 5 years.
- Your symptoms have been stable for the last 6 months, and you haven't changed medications in the last 2 months.
- Your usual medications (including clozapine) haven't helped enough.
- You have moderate to severe 'negative symptoms' (like lack of motivation or emotion).
- You are not pregnant, breastfeeding, or planning to get pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a gentle electric current applied to your head can help with negative symptoms (like lack of motivation or emotion). You must have schizophrenia, take a common antipsychotic, and have some ongoing negative symptoms.
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
This trial tests a special nasal spray gel that combines stem cell exosomes, an antibiotic, and an enzyme to treat chronic sinusitis caused by staph bacteria. It aims to reduce infection and improve symptoms like nasal blockage and discharge.
This study tests whether a nasal spray containing stem cell products can help people recover from autoimmune encephalitis, a condition where the body's immune system attacks the brain. It may reduce symptoms like confusion, memory problems, or seizures.
This study tests a new treatment using tiny particles from stem cells (called exosomes) given as a nasal spray. It aims to see if it can help people with early-onset Alzheimer's disease, which starts before age 65.
This trial tests a nasal drop made from stem cell components. It may act directly in the brain to help slow or treat several conditions like Alzheimer's, Parkinson's, multiple system atrophy, dementia with Lewy bodies, or frontotemporal dementia.
Hear when a new Schizophrenia; Negative Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.